UroGen Pharma Ltd.
URGN | NASDAQ
$43.21
+$0.01 (+0.02%)
Sep 22, 2026, 11:09 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 72.46M | 50.96M | 37.84M | 27.48M | 24.22M | 20.25M | 24.57M | 25.2M | 21.85M | 18.78M | 23.53M | 20.85M | 21.14M | 17.19M | 18.09M | 16.1M | 16.6M | 13.56M | 16.17M | 11.35M | 13.03M | 7.49M |
Cost of Revenue | 6.57M | 4.14M | 3.29M | 3.28M | 3.55M | 2.33M | 2.47M | 2.45M | 2.23M | 1.73M | 2.29M | 2.37M | 2.44M | 2.27M | 2.26M | 2.02M | 1.85M | 1.53M | 1.59M | 1.24M | 1.43M | 897K |
Gross Profit | 65.88M | 46.82M | 34.55M | 24.2M | 20.67M | 17.92M | 22.09M | 22.75M | 19.62M | 17.05M | 21.24M | 18.49M | 18.7M | 14.93M | 15.83M | 14.08M | 14.76M | 12.04M | 14.59M | 10.11M | 11.61M | 6.59M |
Operating Income | 111K | -20.26M | -19.12M | -27.39M | -41.45M | -36.91M | -27.66M | -17.55M | -25.84M | -25.74M | -14.61M | -13.5M | -15.38M | -22.05M | -20.28M | -18.09M | -18.72M | -21.96M | -19.92M | -23.44M | -22.82M | -26.11M |
Interest Income | 946K | 931K | 908K | 1.18M | 1.68M | 2.2M | 2.81M | 2.76M | 1.72M | 1.8M | 726K | 835K | 435K | 645K | 469K | 441K | 128K | 2K | 20K | 57K | 105K | 167K |
Pretax Income | -8.72M | -28.35M | -26.64M | -34.4M | -48.93M | -43.45M | -34.86M | -23.58M | -33.37M | -32.23M | -22.16M | -21.89M | -24.08M | -30.19M | -28.18M | -25.12M | -26.66M | -28.07M | -27.32M | -30.21M | -25.91M | -25.94M |
Net Income | -14.35M | -23.57M | -26.36M | -33.35M | -49.94M | -43.84M | -37.51M | -23.67M | -33.4M | -32.29M | -26.02M | -21.88M | -24.14M | -30.21M | -28.87M | -25.83M | -26.69M | -28.39M | -28.45M | -30.21M | -26.22M | -25.94M |
Selling & General & Admin | 48.44M | 51.49M | 39.35M | 37.58M | 43.2M | 34.97M | n/a | 28.94M | 30.06M | 27.3M | 24.55M | 21.76M | 22.49M | 24.47M | 21.63M | 19.07M | 20.83M | 21.3M | 21.42M | n/a | n/a | n/a |
Research & Development | 17.34M | 15.6M | 14.31M | 14.01M | 18.91M | 19.87M | 14.89M | 11.36M | 15.4M | 15.49M | 11.3M | 10.23M | 11.58M | 12.5M | 14.48M | 13.09M | 12.64M | 12.7M | 13.08M | 11.92M | 12.12M | 10.51M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 34.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.62M | 22.3M | 22.19M |
Operating Expenses | 65.77M | 67.08M | 53.66M | 51.59M | 62.11M | 54.84M | 49.75M | 40.3M | 45.46M | 42.79M | 35.85M | 31.99M | 34.08M | 36.97M | 36.11M | 32.16M | 33.47M | 34M | 34.5M | 33.55M | 34.43M | 32.7M |
Interest Expense | 4.89M | 8.69M | 13.01M | 7.99M | 8.78M | 4.07M | 3.89M | 2.72M | 3.46M | 2.45M | 3.59M | 3.82M | 3.76M | 3.55M | 8.3M | 2.69M | 2.24M | 282K | 7.42M | 6.83M | 3.19M | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 72.35M | 71.22M | 56.95M | 54.87M | 65.66M | 57.17M | 52.22M | 42.75M | 47.69M | 44.52M | 38.14M | 34.35M | 36.52M | 39.24M | 38.37M | 34.18M | 35.32M | 35.52M | 36.09M | 34.79M | 35.86M | 33.6M |
Income Tax Expense | 5.63M | -4.77M | -275K | -1.05M | 1.02M | 392K | 2.65M | 91K | 38K | 54K | 3.85M | -9K | 54K | 21K | 689K | 709K | 32K | 325K | 1.14M | n/a | 312K | n/a |
Shares Outstanding (Basic) | 50.38M | 50.18M | 49.23M | 48.06M | 47.74M | 47.42M | 47.03M | 43.1M | 36.82M | 33.38M | 36.15M | 32.3M | 23.46M | 23.28M | 23.09M | 22.8M | 22.7M | 22.63M | 22.43M | 22.38M | 22.33M | 22.24M |
Shares Outstanding (Diluted) | 50.38M | 50.18M | 49.23M | 48.06M | 47.74M | 47.42M | 47.03M | 43.1M | 36.82M | 33.38M | 36.15M | 32.3M | 23.46M | 23.28M | 23.09M | 22.8M | 22.7M | 22.63M | 22.43M | 22.38M | 22.33M | 22.24M |
EPS (Basic) | -0.28 | -0.47 | -0.54 | -0.69 | -1.05 | -0.92 | -0.80 | -0.55 | -0.91 | -0.97 | -0.72 | -0.68 | -1.03 | -1.30 | -1.22 | -1.13 | -1.18 | -1.25 | -1.27 | -1.35 | -1.17 | -1.17 |
EPS (Diluted) | -0.28 | -0.47 | -0.54 | -0.69 | -1.05 | -0.92 | -0.80 | -0.55 | -0.91 | -0.97 | -0.72 | -0.68 | -1.03 | -1.30 | -1.22 | -1.13 | -1.18 | -1.25 | -1.27 | -1.35 | -1.17 | -1.17 |
EBITDA | -3.76M | -19M | -22.19M | -25.77M | -48.82M | -38.89M | -26.49M | -14.68M | -29.64M | -23.77M | -7.42M | -12.18M | -19.89M | -26.2M | -24.51M | -21.99M | -18.11M | -27.33M | -19.44M | -29.99M | -25.7M | -25.92M |
EBIT | -3.84M | -19.66M | -22.87M | -26.41M | -49.41M | -39.38M | -26.56M | -14.95M | -29.9M | -24.13M | -7.85M | -12.59M | -20.32M | -26.64M | -24.96M | -22.43M | -18.59M | -27.79M | -19.9M | -30.21M | -25.91M | -26.11M |
Depreciation & Amortization | 78K | 652K | 679K | 639K | 596K | 497K | 68K | 266K | 263K | 351K | 424K | 415K | 431K | 435K | 450K | 435K | 476K | 456K | 451K | 217K | 210K | 191K |
Add to Watchlist
Select watchlists to add or remove URGN